Nordic Group is a privately owned pan-European pharmaceutical company with a presence in 17 countries.
It focuses on the development and commercialisation of niche hospital, and orphan products to respond to unmet medical needs. Nordic Group expertise relies on the development and sales of its own products, but also on partner products acquired at various stages of development.
Nordic Group marketing & sales activities are operated in Europe under two different corporate identities
Nordic Drugs operates in the four major Scandinavian
countries i.e. Sweden, Denmark, Norway and Finland.
Nordic Drugs particularly focuses on the primary care
and retail pharmacy markets, but it is as well increasingly present in the
secondary care market. Nordic Drugs has a portfolio of pharmaceutical
specialties, branded generics and a range of OTC products.
Nordic Pharma is focusing its activities to the specialists and hospital
markets in Western, Central & Eastern Europe and South Europe, and in particular in the United Kingdom, Ireland, France, The Netherlands,
Belgium, Germany, Austria, Switzerland, Italy, Spain,
Czech Republic, Slovakia and Poland.
Nordic aims at developing products that address unmet medical needs to healthcare professionals and patients. Today, Nordic has a range of highly specialised proprietary and in-licensed products in the following therapeutic areas:
Nordic Group has affiliates in most European countries and has set up partnerships to promote and distribute its products throughout the world